LFST Stock Recent News

LifeStance Survey Finds Money Stress Significantly Impacts Americans' Mental Health and Ability to Seek Care SCOTTSDALE, Ariz. , July 22, 2025 /PRNewswire/ -- A LifeStance Health survey released today reveals "stressflation" is affecting most Americans, with 83% reporting financial stress driven by inflation, mass layoffs, the rising cost of living and recession fears.

SCOTTSDALE, Ariz., July 17, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter 2025 earnings release before the market opens on Thursday, August 7, 2025.

CSW, ASAN, and others show rising P/E trends -- suggesting breakout potential backed by strong earnings surprises.

LifeStance Health is showing a real turnaround, posting its first-ever net profit and rapidly expanding margins, signaling operational discipline and scalable growth. The company's hybrid care model positions it well amid surging mental health demand, with strong revenue and clinician growth supporting its bullish outlook. Despite a mixed valuation and recent insider selling, institutional investors are accumulating shares, reflecting confidence in LifeStance's long-term margin expansion and platform potential.

LifeStance Health (LFST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

The heavy selling pressure might have exhausted for LifeStance Health (LFST) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

The consensus price target hints at a 45% upside potential for LifeStance Health (LFST). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

SCOTTSDALE, Ariz., May 28, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 46th Annual Goldman Sachs Healthcare Conference, which will be hosted in Miami, Florida.

Live Updates Live Coverage Has Ended Goldman Bullish on Nuclear Stocks 12:05 pm by Gerelyn Terzo Goldman Sachs is bullish on two nuclear stocks – Cameco (NYSE: CCJ) and NuScale Power (NYSE: SMR) – saying they are poised to benefit from the Trump administration’s friendly regulation. Both stocks have rallied by double-digit percentages in recent days. President Trump is determined to bolster domestic uranium production, send advanced reactors to military and energy sites, and tighten the window for new reactor license approvals to 18 months, a process that traditionally is infamous for being extremely lengthy. The markets are holding their gains, including a 2.1% advance in the Nasdaq Composite. Consumer Confidence Soars 10:35 am by Gerelyn Terzo Consumer Confidence surged in May, hitting 98 – a significant 12.3-point jump from April. This robust reading defied economists’ predictions of 86, despite ongoing tariff concerns. The markets are widening their lead,

Live Updates Live Coverage Has Ended Wall Street Endorses Nuclear Stocks 12:10 pm by Gerelyn Terzo Goldman Sachs has issued a bullish report on a pair of nuclear stocks – Cameco (NYSE: CCJ) and NuScale Power (NYSE: SMR) – pointing to regulatory tailwinds from the Trump administration. Both stocks have risen by double-digit percentages since President Trump issued an executive order last week. The president is determined to bolster domestic uranium production, send advanced reactors to military and energy sites, and shorten the wait for new reactor license approvals to one and a half years, a process that historically is known for moving at a snail’s pace. Business Orders Soften 10:30 am by Gerelyn Terzo Durable goods orders posted a 6.3% decline last month, a softer drop than economists had predicted. However, this dip follows four consecutive months of increases, painting a mixed picture for business spending amid ongoing tariff discussions. A significant drag on the overall